Avid Bioservices Inc (CDMO)

[biopharm]

Surely you don't mean Laurence D. Fink, Chairman and CEO, BlackRock, Inc. ? You mean the company that dumped millions of shares of PPHM prior to the run up in 2012, prior to the release of news of sabotage of PPHM's gold standard trial? The company that has amassed millions of shares again?

NH, you are correct... and there can only be so many coincidences before the SEC must investigate and this is plain as day. Anyhow, I find it interesting that Professor Andrew D. Hamilton is coming soon to NYU as President

http://hamilton.chem.ox.ac.uk/

----------------------------------------

On Campus: President-Designate Andrew Hamilton toured the #NYU chemistry labs—where he'll conduct research in 2016.

On Campus: President-Designate Andrew Hamilton toured the #NYU chemistry labs—where he'll conduct research in 2016. pic.twitter.com/3AAGro8e3F

— New York University (@nyuniversity) June 5, 2015

President-Designate Andrew Hamilton toured the NYU chemistry labs this week with Department Chair Jim Canary and Professor Michael Ward. Hamilton will conduct research in the space when he assumes his role in January 2016.

https://www.facebook.com/NYU/posts/10153426010678689

---------------------------------------

March 23, 2015

Two other top candidates dropped out, which left Fenves as the leading candidate. Oxford Vice Chancellor Andrew Hamilton was the front-runner for the position until last week, when he accepted the presidency at New York University.

http://www.texastribune.org/2015/03/23/sources-greg-fenves-next-president-ut-austin/


---------------------------------------

Interesting that Professor ..biochemist.. Andrew Hamilton wanted to announce he'll be conducting research in the lab and if MSK is hot on the trail of PS Targeting, I assume NYU will have no choice.... especially if PS Targeting goes mainstream and Laurence Fink begins to show how many more shares of PPHM he will own on Aug 15, 2015.... ==> 10%+ ownership control of PPHM is my guess